Xiaohui Zhang

发表

Clinical practice of precision medicine in lymphoma

Peng Liu, Yuehua Wu, Yunfeng Cheng, 2022, Clinical and Translational Discovery.

Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study

Jing Liu, Jianda Hu, Y. Li, 2021, Journal of thrombosis and haemostasis : JTH.

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia

Jing Liu, Jie Jin, Jianda Hu, 2021, Journal of Hematology & Oncology.

A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation.

Linhua Yang, Q. Ding, F. Xue, 2019, Thrombosis research.

Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy

Jianxiang Wang, Depei Wu, A. Liang, 2022, Chinese medical journal.

Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study

M. Hou, Junmin Li, Zi-qiang Yu, 2018, Platelets.

Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia

Jie Jin, M. Hou, Junmin Li, 2017, British journal of haematology.

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Ming-Yu Liu, Fei Li, D. Blaise, 2023, Heliyon.

Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study

Q. Ding, F. Xue, T. Zhu, 2017, Scientific Reports.

Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study

Linhua Yang, Q. Ding, F. Xue, 2017, Scientific Reports.